Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin [NA]

View source ↗

Summary

A clinical trial evaluating the in-use tolerance of E45 Eczema Repair Emollient in babies and children with very dry or atopic skin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • E45 Eczema Repair Emollient

Snippet

Sponsor: Reckitt Benckiser Healthcare (UK) Limited | Conditions: Atopic Dermatitis / Eczema | NA | Status: COMPLETED